These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1595650

  • 1. Fecal lysozyme: an unreliable marker for colorectal cancer.
    Dubrow R, Kim CS, Eldred AK.
    Am J Gastroenterol; 1992 May; 87(5):617-21. PubMed ID: 1595650
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fecal protein markers of colorectal cancer.
    Dubrow R, Yannielli L.
    Am J Gastroenterol; 1992 Jul; 87(7):854-8. PubMed ID: 1615938
    [Abstract] [Full Text] [Related]

  • 5. Fecal Adnab-9 binding as a risk marker for colorectal neoplasia.
    Yuan M, Xhang X, Leu Y, Xu Y, Ullah N, Lawson M, Tobi M.
    Cancer Lett; 2006 Apr 08; 235(1):48-52. PubMed ID: 15893419
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
    Leung WK, To KF, Man EP, Chan MW, Hui AJ, Ng SS, Lau JY, Sung JJ.
    Am J Gastroenterol; 2007 May 08; 102(5):1070-6. PubMed ID: 17378912
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening.
    Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU.
    Anticancer Res; 2003 May 08; 23(2A):855-7. PubMed ID: 12820313
    [Abstract] [Full Text] [Related]

  • 17. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
    Johne B, Kronborg O, Tøn HI, Kristinsson J, Fuglerud P.
    Scand J Gastroenterol; 2001 Mar 08; 36(3):291-6. PubMed ID: 11305517
    [Abstract] [Full Text] [Related]

  • 18. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
    Kim Y, Lee S, Park S, Jeon H, Lee W, Kim JK, Cho M, Kim M, Lim J, Kang CS, Han K.
    Ann Clin Lab Sci; 2003 Mar 08; 33(1):32-8. PubMed ID: 12661896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The forms and the levels of fecal PMN-elastase in patients with colorectal diseases.
    Saitoh O, Sugi K, Matsuse R, Uchida K, Matsumoto H, Nakagawa K, Takada K, Yoshizumi M, Hirata I, Katsu K.
    Am J Gastroenterol; 1995 Mar 08; 90(3):388-93. PubMed ID: 7872275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.